On May 2, 2022 Herantis Pharma Plc ("Herantis"), developing disease modifying therapies for Parkinson’s disease, reported that members of the Herantis management team will be attending and holding 1×1 meetings with investors and pharmaceutical companies at the following conferences (Press release, Herantis Pharma, MAY 2, 2022, View Source,c3557941 [SID1234613285]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Nordic Health Summit Japan (Virtual)

Herantis will participate in the Nordic Pitch Showcase session.

1×1 meetings will be scheduled during May 11-13, 2022

Inderes Investment Day May 23, 2022

The presentation will be available on May 23, 2022 in the service of Inderes (www.inderes.fi)

Bio€quity Europe 2022 (Virtual)

The presentation will be live on the Bio€quity Europe platform.

1×1 meetings will be scheduled during May 23-24, 2022

The presentations will be available via digital libraries, which are accessible to event participants only.

Please contact the conference organizers, or send an email to [email protected], if you wish to schedule a meeting with Herantis.